Gam Holding Ag Gilead Sciences, Inc. Transaction History

Gam Holding Ag

$1.14 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$63.15 - $72.88 $190,902 - $220,316	3,023 Added 4.44%	71,090 $4.88 Million
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $405,285 - $494,235	-5,662 Reduced 7.68%	68,067 $4.99 Million
Q3 2023 Oct 16, 2023	BUY	$73.94 - $80.67 $2,292 - $2,500	31 Added 0.04%	73,729 $5.53 Million
Q2 2023 Jul 27, 2023	SELL	$76.01 - $86.7 $8,437 - $9,623	-111 Reduced 0.15%	73,698 $5.68 Million
Q1 2023 May 09, 2023	BUY	$77.31 - $88.08 $44,685 - $50,910	578 Added 0.79%	73,809 $6.12 Million
Q4 2022 Feb 02, 2023	SELL	$62.32 - $89.47 $25,862 - $37,130	-415 Reduced 0.56%	73,231 $6.29 Million
Q3 2022 Oct 19, 2022	SELL	$59.54 - $68.01 $1.76 Million - $2.01 Million	-29,539 Reduced 28.63%	73,646 $4.54 Million
Q2 2022 Jul 21, 2022	SELL	$57.72 - $65.01 $24,588 - $27,694	-426 Reduced 0.41%	103,185 $6.38 Million
Q1 2022 May 06, 2022	SELL	$57.92 - $72.58 $800,338 - $1 Million	-13,818 Reduced 11.77%	103,611 $6.16 Million
Q4 2021 Jan 26, 2022	SELL	$64.88 - $73.64 $1.23 Million - $1.4 Million	-18,955 Reduced 13.9%	117,429 $8.53 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $394,023 - $425,107	-5,821 Reduced 4.09%	136,384 $9.53 Million
Q2 2021 Aug 09, 2021	BUY	$63.47 - $69.35 $233,506 - $255,138	3,679 Added 2.66%	142,205 $9.79 Million
Q1 2021 May 10, 2021	BUY	$60.0 - $68.46 $5.41 Million - $6.17 Million	90,138 Added 186.28%	138,526 $8.95 Million
Q4 2020 Feb 10, 2021	SELL	$56.65 - $64.55 $8.35 Million - $9.52 Million	-147,463 Reduced 75.29%	48,388 $2.82 Million
Q3 2020 Nov 06, 2020	BUY	$62.1 - $78.08 $9,501 - $11,946	153 Added 0.08%	195,851 $12.4 Million
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $2.73 Million - $3.17 Million	-37,768 Reduced 16.18%	195,698 $15.1 Million
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $3.42 Million - $4.38 Million	-54,582 Reduced 18.95%	233,466 $17.5 Million
Q4 2019 Feb 06, 2020	BUY	$61.62 - $67.78 $1.92 Million - $2.11 Million	31,157 Added 12.13%	288,048 $18.7 Million
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $1.57 Million - $1.73 Million	-25,107 Reduced 8.9%	256,891 $16.3 Million
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $862,777 - $967,504	13,945 Added 5.2%	281,998 $19.1 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $3.02 Million - $3.39 Million	48,330 Added 22.0%	268,053 $17.4 Million
Q4 2018 Feb 08, 2019	SELL	$60.54 - $79.0 $2.56 Million - $3.35 Million	-42,345 Reduced 16.16%	219,723 $13.7 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $143,985 - $159,418	2,020 Added 0.78%	262,068 $20.2 Million
Q2 2018 Aug 09, 2018	SELL	$64.88 - $75.68 $111,788 - $130,396	-1,723 Reduced 0.66%	260,048 $18.4 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $1.03 Million - $1.26 Million	-14,193 Reduced 5.14%	261,771 $19.7 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $1.64 Million - $1.92 Million	23,015 Added 9.1%	275,964 $19.8 Million
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $46.6 Million - $55.3 Million	-646,820 Reduced 71.89%	252,949 $20.5 Million
Q2 2017 Aug 07, 2017	BUY	N/A	899,769	899,769 $63.7 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on Gam Holding Ag with notifications on news.

Account